ACEP Scientific Assembly Boston ’21

Omni-stat Medical Inc will be exhibiting at ACEP 2021 the American College of Emergency Physicians 2021 National Scientific Assembly Meeting Oct 25 – 28th, at the Boston Convention and Exhibition Center.  If you are attending this long awaited in-person meeting our team would love to meet you at Booth #2503 to introduce our fast acting line of hemostatic agents.

ACEP21 & Omni-stat Medical Inc are excited for everyone to come together for education, social activities, and networking! This year ACEP will also offer live streaming of courses to accommodate all attendees. We can’t wait to be back together at ACEP21!


Fast Acting Hemostatic Agents can help reduce blood loss and save lives.

Excessive bleeding can put patients at risk and lead to complications, including death. According to a 2018 review, every year more than 60,000 Americans die from uncontrolled hemorrhage or blood loss.1
Fast Acting Hemostatic Agents can help reduce blood loss and save lives. Those that work independent of the body’s natural clotting cascade may offer benefits to patients with impaired coagulation. Omni-stat Medical Inc provides solutions for bleeding control. Our unique patented chitosan-technology has been proven on the battlefield2 and is trusted by hospitals.

Omni-Stat Granules with Exterior Sterile Pouch Celox-A - celox granule applicator

Highest Rate of observed survival in independent testing2,3
Proven Effective in the presence of common anticoagulants4 and in hypothermic conditions5
Saves Time, stops bleeding in as little as 1 minute⁵ and significantly reduces OR time6

1. (Cannon, J. (2018, January 25). Hemorrhagic Shock. The New England Journal of Medicine, 378, 370-9). 2. Winstanley M, Smith JE, Wright C. Catastrophic haemorrhage in military major trauma patients: a retrospective database analysis of haemostatic agents used on the battlefield. J R Army Med Corps 2018;0:1-5. 3. Rall JM, Cox JM, Songer A, Comeaux JA, Estep JS, Cestero RF, Ross JD. Comparison of novel hemostatic dressings with QuikClot combat gauze in a standardized swine model of uncontrolled haemorrhage. J Trauma Acute Care Surg 2013; 75 (2 Suppl 2):S150-S156. 4. Johnson L, Luksch P, Ranfield J, Hardy C. The laboratory assessment of a new hemostat able to clot blood containing anticoagulants. Presented at the 21st Annual Symposium on Advanced Wound Care and the Wound Healing Society, San Diego, 2008. 5. Data on file at Omni-stat Medical Inc. Laboratory testing has shown the product to be effective in blood temperatures down to 56°F (13°C). 6. Thibodeaux, KT, Speyrer, MS, Thibodeaux, RP, Rogers, AA, Rippon, MG. Management of postoperative bleeding in surgically debrided wounds: topical haemostat versus electrocautery. Journal of Wound Care 2020; 29(8): 444-451


Click here to receive a voucher for a FREE product sample at the booth

 

 


Not able to attend, click here to request more information about our products or to speak with a local sales representative

 

Featured Products

Contact

Omni-stat Medical Inc

New York – SoHo – Hudson Square,
101 Avenue of the Americas,
8th and 9th Floors,
New York, NY 10013,
USA

Proud to be an Official Partner of

Stop the Bleed
Inquire Here

General Inquiries

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

Product Inquiry

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

Order Inquiry

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

OMNI-STAT® Clinical and Scientific Monograph

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

Request a Product Demonstration

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

Please select a valid form.

Request an In-Service

Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com

Please select a valid form.

This website uses Cookies to improve your browsing experience. View Cookies Policy

I'm fine with this